Source · Prevention of Future Deaths

David Mason

Ref: 2023-0125 Date: 19 Apr 2023 Coroner: Nicholas Lane Area: Worcestershire Responses identified: 6 / 5 View PDF

Clinicians across emergency, surgical, and pre-hospital care failed to recognise the need for additional steroid therapy for a patient with Addison's disease after trauma. Trust guidelines and documentation lacked crucial prompts for adrenal insufficiency.

Date 19 Apr 2023
56-day deadline 14 Jun 2023
Responses identified 6 of 5
Hospital Death (Clinical Procedures and medical management) related deaths

Coroner's concerns

AI summary
Clinicians across emergency, surgical, and pre-hospital care failed to recognise the need for additional steroid therapy for a patient with Addison's disease after trauma. Trust guidelines and documentation lacked crucial prompts for adrenal insufficiency.
View full coroner's concerns
(numbered separately in respect of each organisation, who are required to respond to each of the numbered paragraphs relating to them):

Worcestershire Acute Hospitals NHS Trust (WAHT)

1) Evidence heard at the inquest demonstrated that no clinician involved in providing care to Mr Mason (in both the emergency department and the surgical trauma department) appreciated that, as someone who had Addison’s disease and who had suffered the trauma of a fall, long lie and a fractured hip, Mr Mason required additional replacement steroid therapy, to prevent the development of an acute adrenal crisis.

2) The relevant internal Trust guideline disclosed by WAHT (‘Guideline for the management of adrenal insufficiency in adults’) very much focuses on presentations of acute adrenal crisis and procedure-based/perioperative situations, and (save for a small section containing ‘sick day’ rules, which are on the same page as advice to patients and families for long-term condition management) does not emphasise that replacement steroid therapy must be given to patients with adrenal insufficiency who have suffered trauma or physiological stress.

3) Evidence heard at the inquest (relating to the trauma/surgical department at WAHT) suggested that it is likely that many clinicians (including at consultant level) do not have a well-developed understanding of adrenal insufficiency and the crucial importance of administering replacement steroid therapy to patients who, although not presenting as acutely unwell, are at risk of suffering an adrenal crisis.

4) Evidence heard at the inquest confirmed that no prompts exist on emergency department/clerking documentation at WAHT for clinicians to check whether a patient suffers from adrenal insufficiency. Although the inquest was informed that changes have been made in this regard by WAHT to some peri-operative patient documentation, the National Patient Safety Alert (NatPSA/2020/005/NHSPS) requires acute trusts to review admission/assessment/clerking documentation to ensure such prompts are included.

West Midlands Ambulance Service University NHS Foundation Trust (WMAS)

1) Evidence heard at the inquest demonstrated that no clinician involved in providing pre-hospital care to Mr Mason appreciated that, as someone who had Addison’s disease and who had suffered the trauma of a fall, long lie and a fractured hip, Mr Mason required additional replacement steroid therapy, to prevent the development of an acute adrenal crisis.

2) Evidence heard at the inquest demonstrated that when information is given to an EOC (emergency operations centre) call-handler at WMAS that a patient has a diagnosis of Addison’s disease and has suffered trauma, the call-handler question pathway (which, the inquest heard, is based on a computer-programmed logarithm (designed by NHS Digital, now part of NHS England)) does not go on to consider the risk of adrenal insufficiency and the requirement for replacement steroid therapy to commence immediately. This appears to be potentially relevant both in respect of whether time-critical steroid treatment may be required (and thus for a holistic consideration of call categorisation) and safety-netting advice that should be given (for additional doses of steroid medication to be taken by the patient, prior to any ambulance arrival). Safety-netting advice takes on even greater significance in the current climate, where healthcare demand and pressures on capacity are often causing severe delays in ambulance attendance. Evidence heard at the inquest confirmed that the position is different if information is given that the patient is medically unwell, particularly if concerns of a cardiac nature are present or adrenal insufficiency may be the direct cause of current illness, with the call-handler question pathway then going on to consider the risk of adrenal insufficiency. Currently there is a cohort of patients (which included Mr Mason) whose risk of developing an adrenal crisis is not being considered by call-handlers at WMAS.

3) The Serious Incident investigation report disclosed by WMAS did not make any recommendations in respect of improving clinicians’ knowledge of adrenal insufficiency and the importance of considering administering replacement steroid therapy.

4) Evidence heard at the inquest confirmed that the investigation lead at WMAS had not been shown the inquest disclosure bundle, which had been disclosed to the legal department at WMAS a number of months prior to the inquest. This bundle contained relevant evidence from a different internal investigation (by WAHT), suggesting that the likely cause of Mr Mason’s deterioration and death was an acute adrenal crisis and not, as had been considered when a coronial referral had initially been made, hyperkalaemia and rhabdomyolysis (following a fall and long lie). This lack of internal co-ordination within WMAS prevented full internal investigation and learning in respect of the care given to Mr Mason by WMAS. The legal department of WMAS did not attend the inquest (it was their right not to) nor were WMAS legally represented by an external solicitor or barrister (it was their right not to be). Greater engagement and participation in the coronial investigation and inquest process would improve the Trust’s ability to learn from patient-safety incidents and enable the legal, governance and safety departments to better co-ordinate such investigations.

Association of Ambulance Chief Executives (AACE)

1) The relevant JRCALC (Joint Royal Colleges Ambulance Liaison Committee) guideline for steroid dependent patients (which was disclosed by WMAS as part of inquest proceedings) places very little emphasis on the importance of administering steroid replacement therapy to patients who, although not presenting as acutely unwell, are at risk of developing an acute adrenal crisis, owing to them suffering from trauma or physiological stress. The relevant section (contained in bullet point 2 of the ‘administer hydrocortisone’ box) is itself a sub-section of an ‘emergencies in adults and children’ box and therefore is not able to be easily differentiated from treatment required for patients who are already established as being in an emergency situation. Further, it is stated that patients who are ‘unwell’ require hydrocortisone to prevent an adrenal crisis – it is not sufficiently clear that patients who may have suffered trauma or physiological stress also require steroid treatment, to prevent an adrenal crisis. To lend weight to this latter concern, evidence heard at the inquest suggested that the clinicians involved in treating Mr Mason considered ‘unwell’ in this context to mean obviously medically unwell, such as having signs of infection or sepsis, or gastro-intestinal symptoms, such as diarrhoea. There was no evidence of any understanding that this definition encompasses patients who have suffered trauma or physiological stress.

2) Evidence heard at the inquest demonstrated that when information is given to an EOC (emergency operations centre) call-handler at WMAS that a patient has a diagnosis of Addison’s disease and has suffered trauma, the call-handler question pathway (which, the inquest heard, is based on a computer-programmed logarithm (designed by NHS Digital, now part of NHS England)) does not go on to consider the risk of adrenal insufficiency and the requirement for replacement steroid therapy to commence immediately. This appears to be potentially relevant both in respect of whether time-critical medical treatment may be required (and thus for a holistic consideration of call categorisation) and safety-netting advice that should be given (for additional doses of steroid medication to be taken by the patient, prior to any ambulance arrival). Safety-netting advice takes on even greater significance in the current climate, where healthcare demand and pressures on capacity are often causing severe delays in ambulance attendance. Evidence heard at the inquest confirmed that the position is different if information is given that the patient is medically unwell, particularly if concerns of a cardiac nature are present or adrenal insufficiency may be the direct cause of current illness, with the call-handler question pathway then going on to consider the risk of adrenal insufficiency. The pathway and programmed-logarithm should be looked at, as currently there is a cohort of patients (which included Mr Mason) whose risk of developing an adrenal crisis is not able to be considered by ambulance service control centres.

National Institute for Health and Care Excellence (NICE)

1) The relevant treatment guideline disclosed by WAHT (‘Guideline for the management of adrenal insufficiency in adults’) very much focuses on presentations of acute adrenal crisis and procedure-based/perioperative situations, and (save for a small section containing ‘sick day’ rules) does not emphasise that replacement steroid therapy must be given to patients with adrenal insufficiency who have suffered trauma or physiological stress. Evidence heard at the inquest suggested that this internal Trust guideline (and, one assumes, other such guidelines in other acute trusts in the country) is based upon various pieces of national guidance. It is my understanding that a new guideline in respect of managing the treatment of adrenal insufficiency is currently being developed by NICE. Consideration of these matters should be included as part of guideline development.

Society for Endocrinology (Clinical Committee)

1) The relevant treatment guideline disclosed by WAHT (‘Guideline for the management of adrenal insufficiency in adults’) very much focuses on presentations of acute adrenal crisis and procedure-based/perioperative situations, and (save for a small section containing ‘sick day’ rules) does not emphasise that replacement steroid therapy must be given to patients with adrenal insufficiency who have suffered trauma or physiological stress. Evidence heard at the inquest suggested that this internal Trust guideline (and, one assumes, other such guidelines in other acute trusts in the country) is based upon various pieces of national guidance. The clinical committee of the Society for Endocrinology has previously been involved in providing guidance in respect of managing patients with adrenal insufficiency. The Society’s input going forward is important in respect of considering any future NICE or JRCALC guidelines regarding the management of adrenal insufficiency.

2) The relevant JRCALC (Joint Royal Colleges Ambulance Liaison Committee) guideline for steroid dependent patients (which was disclosed by WMAS as part of inquest proceedings) place very little emphasis on the importance of administering steroid replacement therapy to patients who, although not presenting as acutely unwell, are at risk of developing an acute adrenal crisis owing to them suffering from trauma or physiological stress. The relevant section (contained in bullet point 2 of the ‘administer hydrocortisone’ box) is itself a sub-section of an ‘emergencies in adults and children’ box and therefore is not able to be easily differentiated from treatment required for patients who are already established as being in an emergency situation. Further, it is stated that patients who are ‘unwell’ require hydrocortisone to prevent an adrenal crisis – it is not sufficiently clear that patients who may have suffered trauma or physiological stress also require steroid treatment, to prevent an adrenal crisis. To lend weight to this latter concern, evidence heard at the inquest suggested that some of the clinicians involved in treating Mr Mason considered ‘unwell’ in this context to mean obviously medically unwell, such as having signs of infection or sepsis, or gastro-intestinal symptoms, such as diarrhoea. There was no evidence of any understanding that this definition encompasses patients who have suffered trauma or physiological stress. The Society’s input going forward is important in respect of considering any future NICE or JRCALC guidelines regarding the management of adrenal insufficiency.

NHS England

1) Evidence heard at the inquest demonstrated that when information is given to an EOC (emergency operations centre) call-handler at WMAS that a patient has a diagnosis of Addison’s disease and has suffered trauma, the call-handler question pathway (which, the inquest heard, is based on a computer-programmed logarithm (designed by NHS Digital, now part of NHS England)) does not go on to consider the risk of adrenal insufficiency and the requirement for replacement steroid therapy to commence immediately. This appears to be potentially relevant both in respect of whether time-critical medical treatment may be required (and thus for a holistic consideration of call categorisation) and safety-netting advice that should be given (for additional doses of steroid medication to be taken by the patient, prior to any ambulance arrival). Safety-netting advice takes on even greater significance in the current climate, where healthcare demand and pressures on capacity are often causing severe delays in ambulance attendance. Evidence heard at the inquest confirmed that the position is different if information is given that the patient is medically unwell, particularly if concerns of a cardiac nature are present or adrenal insufficiency may be the direct cause of current illness, with the call-handler question pathway then going on to consider the risk of adrenal insufficiency. The pathway and programmed-logarithm should be looked at, as currently it appears that there is a cohort of patients (which included Mr Mason) whose risk of developing an adrenal crisis is not able to be considered by ambulance service control centres.

2) Evidence heard at the inquest confirmed that no prompts exist on emergency department/clerking documentation at WAHT for clinicians to check whether a patient suffers from adrenal insufficiency. Although the inquest was informed that changes have been made in this regard by WAHT to some peri-operative patient documentation, the National Patient Safety Alert (NatPSA/2020/005/NHSPS) requires acute trusts to review admission/assessment/clerking documentation to ensure such prompts are included. It is not clear what follow-up action is taken by NHS England in relation to monitoring of compliance by NHS Trusts following National Patient Safety Alerts being issued.

Responses

6 respondents
NHS England NHS / Health Body
19 Apr 2023 PDF
Action Planned

NHS England reports that the JRCALC guidelines will be amended to improve understanding of administering steroids in cases of trauma, and that a Regulation 28 Working Group discusses all PFD reports to identify emerging trends. (AI summary)

View full response
Dear Mr Lane,

Re: Regulation 28 Report to Prevent Future Deaths – David Ernest Mason who died on 7 March 2022.

Thank you for your Report to Prevent Future Deaths (hereafter “Report”) dated 19 April 2023 concerning the death of David Ernest Mason on 7 March 2022. In advance of responding to the specific concerns raised in your Report, I would like to express my deep condolences to David’s family and loved ones. NHS England are keen to assure the family and the coroner that the concerns raised about David’s care have been listened to and reflected upon.

I address the two concerns addressed to NHS England within your report below.

Concern One: That certain ambulance call-handler pathways do not allow for patients at risk of developing an adrenal crisis to be adequately considered by ambulance service control centres.

NHS Pathways is a telephone and digital triage Clinical Decision Support System (CDSS) that has been in use since 2005 within the Urgent and Emergency care setting. It is used in all NHS 111 and over half of the English ambulance services, including West Midlands Ambulance Service University NHS Foundation Trust (WMAS).

The safety of the clinical triage process endpoints resulting from a 111 or 999 assessment using NHS Pathways is overseen by the National Clinical Assurance Group, an independent intercollegiate group hosted by the Academy of Medical Royal Colleges (AoMRC). Alongside this independent oversight, NHS Pathways ensures its clinical content and assessment protocols are consistent with the latest advice from respected bodies that provide evidence and guidance for clinical practice in the UK. This includes latest guidelines from
a. NICE (National Institute for Health and Care Excellence).
b. The UK Resuscitation Council; and
c. The UK Sepsis Trust.

The system is built around a clinical hierarchy, meaning that life-threatening symptoms are assessed at the start of the call triggering ambulance responses, progressing National Medical Director NHS England Wellington House 133-155 Waterloo Road London SE1 8UG

14 June 2023

through to less urgent symptoms which require a less urgent response (or disposition) in other settings. NHS Pathways is not diagnostic, but instead works on the basis of 'ruling out'. This means that questions are asked in order to rule out possible reasons for the patient’s symptoms, until a point where it is safe for the patient to manage their own symptoms with advice or further intervention is needed by a clinician to establish a possible cause.

The majority of calls taken using NHS Pathways are handled by a highly trained but non-clinical Health Advisor. Health Advisors (as per the NHS Pathways Provider Licence) should have access to support from clinicians to support safe call-handling. Even though thorough training is provided, it is not within the remit of the Health Advisor to be trained in, or understand more complex medical elements, such as in this case. Indeed, such enquiry can add confusion and delays to the management of the case and triaging process. It is for these reasons that questions on past medical history or pharmacology are utilised sparingly across the system, and only where it is deemed that a clear understanding can be sought.

If a patient is unconscious the lowest disposition (outcome) they can reach would be a Category 2 emergency ambulance, and questions around adrenal insufficiency do not present because it will not impact the category of ambulance. However, after dispatch the system goes on to ask whether the caller has known adrenal insufficiency and, if so, offers specific in-line advice about administration of an emergency steroid kit.

Patients with adrenal insufficiency, such as David, are often knowledgeable about their condition and have specific instructions from their specialist on when and how to use emergency treatment kits. Injuries are common in the general population, but the prevalence of adrenal insufficiency across that population, whose triage assessment is supported by the NHS Pathways system, is relatively infrequent. If a patient with adrenal insufficiency is conscious at the time of a call, the risk posed through extra questioning on complex themes is thought to outweigh the urgency of advice. Adding enquiries about a topic where, (a) affected patients are likely to be aware of what to do and (b) such enquiries would delay the care or add confusion in the management of unaffected patients, has been considered and balanced in the design of this system and endorsed by the National Clinical Assurance Group.

However, having learned of this case, NHS Pathways will engage with its stakeholders and monitor emerging evidence and guidelines with respect to emergency steroid replacement therapy in the pre-hospital setting, with a view to making system changes where appropriate in accordance with the governance framework. If it is established that system-wide changes are required, NHS Pathways will work closely with colleagues in the ambulance sector to ensure safety-netting advice is appropriate.

NHS England will also engage with Medical Priority Dispatch System, the suppliers of the alternative telephone and digital triage system used by ambulance services in England, to review their processes for assessing adrenal insufficiency.

Concern Two: It was not clear what follow-up action is being taken by NHS England with regard to monitoring of compliance by NHS Trusts with National Patient Safety Alerts. In this case, alert NatPSA/2020/005/NHSPS, requiring

acute trusts to review admission/assessment/clerking documentation to ensure clinicians are prompted to check whether patients suffer from adrenal insufficiency.

NHS England has worked closely with the Society for Endocrinology and the Royal College of Physicians on the issue of under-recognition and treatment of adrenal insufficiency or crisis. This culminated in the publication of ‘Guidance for the prevention and emergency management of adult patients with adrenal insufficiency’ in July 2020, which outlines the causes of adrenal insufficiency, groups at risk of an adrenal crisis, emergency management and management for surgical procedures. As a result of work in this area, a new NHS Steroid Emergency Card was developed, to be carried by patients at risk of adrenal crisis and ensure the prompt delivery of steroids to those patients presenting within an emergency or acute medicine setting.

The work above also resulted in the publication of the National Patient Safety Alert (NatPSA), mentioned in your report, which includes the specific action that ‘Providers that treat patients with acute physical illness or trauma, or who may require emergency or elective surgical or other invasive procedures, including day patients, should review their admission/assessment/examination/clerking documentation to ensure it includes prompts to check for risk of adrenal crisis and to establish if the patient has a Steroid Emergency Card.’ Trusts were expected to implement actions around this specific alert by 13 May 2021.

Alert compliance data for NatPSAs is published monthly on the Central Alerting System website. Guidance issued to NHS staff in August 2022, outlines the separate roles and responsibilities of the national Patient Safety Team, the region, the Integrated Care Board (ICB) and the providers regarding issuing and complying with alerts. The national team at NHS England has statutory responsibilities for identifying new or under-recognised issues and issuing NatPSAs when required but are not responsible for overseeing compliance. It is the role of ICBs to have local mechanisms in place to support compliance with any actions required in NatPSAs, in line with NHS Standard Contract requirements and the national Patient Safety Strategy. Regions and ICBs are expected to have sight of providers who do not complete actions by the required dates and provide support and assurance where this occurs.

In this case, Worcestershire Acute Hospitals NHS Trust declared compliance in March
2022. There are currently three Trusts who remain non-compliant. The national team at NHS England has asked regional colleagues to engage with the relevant ICBs regarding these Trusts. It is ultimately the role of the Care Quality Commission (CQC) to ensure the implementation of actions set out in alerts, which is made clear in all NatPSAs, through the following statement; ‘Failure to take the actions required under this National Patient Safety Alert may lead to CQC taking regulatory action’.

Other considerations

NHS England has also engaged with the Association of Ambulance Chief Executives (AACE), on the concerns raised in your report. The AACE are responsible for the Joint Royal Colleges Ambulance Liaison Committee UK ambulance service clinical practice guidelines (JRCALC guidelines). The guidelines advise that ambulance services in the UK should carry hydrocortisone on their vehicles. The AACE had previously reviewed

what process each UK ambulance service had in place regarding adrenal insufficiency, with all services responding that paramedics were able to administer hydrocortisone for the emergency treatment of adrenal insufficiency, together with most technicians/non-registered staff.

Following our engagement with the AACE, we have been advised that there will be some amendments made to the JRCALC guidelines for steroid dependent patients, to help improve understanding of the need for administering steroids in cases of trauma. These amendments have already been drafted and will be published shortly.

I would also like to provide further assurances on national NHS England work taking place around Reports to Prevent Future Deaths. All reports received are discussed by the Regulation 28 Working Group, comprising Regional Medical Directors, and other clinical and quality colleagues from across the regions. This ensures that key learnings and insights around preventable deaths are shared across the NHS at both a national and regional level and helps us pay close attention to any emerging trends that may require further review and action.

Thank you for bringing these important patient safety issues to my attention and please do not hesitate to contact me should you need any further information.
National Institute for Health and Care Excellence Other
19 Apr 2023 PDF
Noted

NICE acknowledges the concerns and notes that its new guideline on adrenal insufficiency covers identification, emergency management, and prevention of adrenal crisis during physiological stress, including trauma. The guideline committee includes paramedic co-optees and other relevant health professionals. (AI summary)

View full response
Dear Mr Lane, Re: Regulation 28 Prevention of Future Deaths letter David Ernest Mason, deceased I write in response to your regulation 28 report of 19 April 2023 regarding the very sad death of Mr David Ernest Mason. I would like to express my sincere condolences to Mr Mason's family. We have reflected on the circumstances surrounding Mr Mason's death, and the concerns raised in your report. We note your suggestion that the issues raised in your report should be considered in the development of our new guideline on adrenal insufficiency, particularly that replacement steroid therapy must be given to patients with adrenal insufficiency who have suffered trauma or physiological stress. I can confirm that the scope of this guideline covers adrenal crisis including identification and emergency management and preventing adrenal crisis during periods of physiological stress, which includes trauma. Membership of the guideline committee recruited for this topic includes two paramedic co-optees, as well as health professionals who see people with adrenal crisis or who are at risk of adrenal crisis in the emergency department. Please do let me know if you require any further information and again, I offer my sincerest condolences to Mr Mason's family.
West Midlands Ambulance Service NHS / Health Body
1 Jun 2023 PDF
Action Taken

WMAS highlighted existing JRCALC guidance updates regarding steroid usage for adrenal crisis (2017, 2020, 2022), communication to staff via clinical times briefings, and the introduction of steroid emergency cards. WMAS also apologized for an administrative error that led to the lead investigator not receiving the inquest disclosure bundle and stated that the legal team aims to attend as many inquests as possible. (AI summary)

View full response
Dear Mr Lane Re: Regulation 28 Report to Prevent Future Deaths – David Ernest Mason (Deceased) Thank you for your email dated 20 April 2023 attaching your Regulation 28 Report. Firstly, I am sorry that you have had to raise concerns with West Midlands Ambulance Service University NHS Foundation Trust (WMAS) following the inquest of Mr Mason. Can I please take this opportunirty to pass on my sincere condolences to the family of Mr Mason. Please see our response to your concerns. Concern 1 Evidence heard at the inquest demonstrated that no clinician involved in providing pre- hospital care to Mr Mason appreciated that, as someone who had Addison’s disease and who had suffered the trauma of a fall, long lie and a fractured hip, Mr Mason required additional replacement steroid therapy, to prevent the development of an acute adrenal crisis. Response In 2017 there was an update in the Joint Royal Colleges Ambulance Liaison Committee (JRCALC) guidance emphasising the increased usage of Hydrocortisone for patients with adrenal crisis, including a further note stating if in doubt administer Hydrocortisone. This was communicated to all staff through the clinical times edition
30. The clinical times is an internal quarterly breifing which provides all staff with new or updated clinical guidance. In September 2020 under the medical emergencies section of JRCALC was updated to highlight that a joint National Patient Safety Alert was issued by NHS Improvement and NHS England about Steroid Emergency Cards to support early recognition and treatment of adrenal crisis in adults. Small amendments were made in the guidelines to highlight the need to be alert for a patient having an emergency card for a specific condition. For example a steroid emergency card or an alert card for a patient with COPD regarding oxygen therapy. This was highlighted to all staff through clinical notice 431.

In February 2022 JRCALC issued a new guideline titled steroid dependant patients, this guideline was highlighted to all staff through clinical notice 484. This also included permitting WMAS ambulance technicians to administer hydrocortisone IM to patients as well as Paramedics. All WMAS clinicians are given access to the JRCALC guidelines through individual licenses for the JRCALC Plus app. Staff are also provided a Trust personal issue Ipad and the app can be accessed through this device, or there is the option for the app to be also downloaded on other devices such as personal smart phones if they so choose so. This allows clinicians to access the guidelines whilst at the patient side. As well as the above a number of articles have been run within the WMAS weekly briefing. The weekly breifing which is emailed to all WMAS employees provides all the latest information about WMAS and any changes to guidance that have been made by external bodies in relation to clinical practice that must be considered. An example of such is below: Steroid Emergency Card All clinicians are to be aware of recently published national guidance that promotes a new patient-held Steroid Emergency Card. The guidance and card are designed to help healthcare staff identify adrenal crisis in adults and gives information on the emergency treatment to start if the patient is acutely ill, or experience trauma, surgery or other major stressors. For further information please go to:

Concern 2 Evidence heard at the inquest demonstrated that when information is given to an EOC (emergency operations centre) call-handler at WMAS that a patient has a diagnosis of Addison’s disease and has suffered trauma, the call-handler question pathway (which, the inquest heard, is based on a computer-programmed logarithm (designed by NHS

Digital, now part of NHS England)) does not go on to consider the risk of adrenal insufficiency and the requirement for replacement steroid therapy to commence immediately. This appears to be potentially relevant both in respect of whether time- critical steroid treatment may be required (and thus for a holistic consideration of call categorisation) and safety-netting advice that should be given (for additional doses of steroid medication to be taken by the patient, prior to any ambulance arrival). Safety- netting advice takes on even greater significance in the current climate, where healthcare demand and pressures on capacity are often causing severe delays in ambulance attendance. Evidence heard at the inquest confirmed that the position is different if information is given that the patient is medically unwell, particularly if concerns of a cardiac nature are present or adrenal insufficiency may be the direct cause of current illness, with the call-handler question pathway then going on to consider the risk of adrenal insufficiency. Currently there is a cohort of patients (which included Mr Mason) whose risk of developing an adrenal crisis is not being considered by call-handlers at WMAS. Response Calls to 999 are assessed in accordance with the Department of Health National Guidelines using a process called NHS Pathways (NHSP). NHSP is a patient assessment triage tool used to determine the most suitable level of care, appropriate to the presenting symptoms of the telephone call. It is a national requirement to use an assessment system to triage all 999 calls, to assist Ambulance Services in prioritising the high number of calls received. WMAS are unable to make changes to the system. WMAS Integrated Emergency Urgent Care Clinical Commander who is the Lead for NHS Pathways (NHSP) has raised the above as a clinical concern on the NHSP log. WMAS are awaiting a response from Pathways. Concern 3 The Serious Incident investigation report disclosed by WMAS did not make any recommendations in respect of improving clinicians’ knowledge of adrenal insufficiency and the importance of considering administering replacement steroid therapy. Response Following review of the serious incident investigation and receipt of the PFD we agree a recommendation should have been made to raise awareness and improve clinicians knowledge of adrenal insufficiency and the importance of considering adminsertering replacement steroid therapy. Therefore we have reemphasised the care of the steroid dependant patient with an in depth article with appropriate links for further reading and education, publishing the below in the clinical times on the 12th of May 2023. Steroid Dependant Patients - Jason Wiles, Consultant Paramedic for Emergency Care Following a recent coronial inquest, the Trust received a Regulation 28 Report to Prevent Future Deaths in relation to clinicians’ knowledge adrenal insufficiency and the importance of considering administering replacement steroid therapy particularly in the patient who has suffered the trauma of a fall, long lie and a fractured hip. In this

case the patient required additional replacement steroid therapy, to prevent the development of an acute adrenal crisis. JRCALC provide guidance on the assessment and management of Steroid- dependent patient which are available to all clinicians through the JRCALC+ app. Incidence  Primary Adrenal insufficiency (when the adrenal glands cannot produce cortisol) affects 1 in 20,000 people in western Europe affecting around 3,400 people in the UK.  Secondary Adrenal insufficiency (when the pituitary gland cannot produce ACTH, and therefore cannot stimulate the adrenal gland to produce cortisol) is more common with 150 – 280 people per million affected. It is more common in women than men. The peak age of onset is between 50 and 60 years. Pathophysiology Glucocorticoid Steroid Dependant Patients The cause of steroid dependency can be broken down into three types: primary, secondary, and tertiary.
1. Primary adrenal insufficiency occurs in patients who have direct impairment of the adrenal glands such as those with Addison’s disease (autoimmune endocrine condition where the adrenal glands cease to function), congenital adrenal hyperplasia (genetic condition) or surgery or trauma to the adrenal glands.
2. Secondary adrenal insufficiency is caused by pituitary disease, hypothalamic or pituitary tumours and their treatment (surgery and radiotherapy) or brain injury.
3. Tertiary adrenal insufficiency may occur in patients who have taken steroids for prolonged periods of time, high doses, multiple courses, or via multiple routes.. Prolonged use may lead to a reduction or cessation of naturally occurring cortisol production by the adrenal glands. Regardless of type, those with adrenal insufficiency are at risk of adrenal crisis which can be life threatening. Adrenal Crisis Adrenal crisis, also termed acute adrenal insufficiency, is a life-threatening endocrine emergency due to a lack of production of the adrenal hormone cortisol. Adrenal crisis can also occur if existing cortisol replacement does not meet the body’s increased need for cortisol due to illness such as fever, persistent vomiting or diarrhoea or trauma. Equally, sudden cessation of corticosteroid medication for conditions listed above, will risk adrenal crisis in those with adrenal insufficiency. Identifying patients at risk and prompt management can save lives. National guidance promotes a new patient-held Steroid Emergency Card to help healthcare staff identify patients with adrenal insufficiency and provide information on emergency treatment if the patient is acutely ill, experiences trauma, surgery or other major stressors.

emergency-card-to-support-early-recognition-and-treatment-of-adrenal-crisis-in­ adults/

Assessment and Management Assessment and management of: Steroid Dependant Patients or at risk of adrenal insufficiency Assessment  Assess <C>ABCD MANAGEMENT  If any of the following TIME CRITICAL features present:  Major <C>ABCD problems, refer to Medical Emergencies in Adults – Overview and Medical Emergencies in Children – Overview  Start correcting <C>ABCD problems.  Undertake a TIME CRITICAL transfer to nearest receiving hospital.  Continue patient management en-route.  Provide an ATMIST information call. Symptoms and signs of adrenal insufficiency include:  Severe fatigue, lethargy, drowsiness, confusion, coma  Low blood pressure, postural dizziness and hypotension (≥20 mmHg drop in BP from supine to standing position), dizziness, collapse, in severe cases hypovolaemic shock  Abdominal pain, tenderness and guarding, anorexia, nausea, vomiting (in particular in primary adrenal insufficiency), diarrhoea  Fever  Patients may have a history of weight loss and increasing skin pigmentation over weeks to months (primary adrenal insufficiency)  Assess patient for underlying acute conditions that may have precipitated the adrenal crisis and treat that condition too. Follow Medical Emergencies in Adults – Overview and Medical Emergencies in Children – Overview in addition to the specific management detailed below.

 Measure and record pulse rate.  Measure and record respiratory rate.  Measure oxygen saturations  Measure and record blood glucose for hypoglycaemia.  Treat hypoglycaemia. Refer to Glycaemic Emergencies in Adults and Children.  Measure and record temperature.  These observations along with a blood pressure will enable you to calculate a NEWS2 Score, refer to Sepsis.  If required, monitor and record 12-Lead ECG. Assess for abnormality, refer to Cardiac Rhythm Disturbance.  Measure and record blood pressure, if required administer fluids, refer to Intravascular Fluid Therapy in Adults and Intravascular Fluid Therapy in Children.  Patients with adrenal crisis may be hypotensive or have postural hypotension. Assess for postural hypotension if normotensive when lying / sitting.  There may be a profound postural drop in blood pressure when the patient is moved from the lying position to semi-recumbent or sitting position. It may be necessary to give IV fluids prior to moving the patient if extrication requires head up posture. Administer Hydrocortisone Administer hydrocortisone to:  Patients in an established adrenal crisis (IV or IM administration). Ensure parenteral hydrocortisone is given prior to transportation.  Patients with suspected adrenal insufficiency or on long-term steroid therapy who have become unwell or experience trauma to prevent them having an adrenal crisis. IM administration is usually sufficient.  If in doubt about adrenal insufficiency hydrocortisone should be administered.  Pregnant women who have Addison’s disease who are established in labour (regular painful contractions) should receive Hydrocortisone.  Refer to Hydrocortisone drug guideline. Conveyance to hospital  Convey patients who have required intravenous fluids or management of hypoglycaemia.  Convey patients if the underlying condition precipitating the adrenal crisis needs hospital assessment / management. Consider management in the community or referral to other services for:  Patients with mild illness / injury where they have followed their treatment plan to increase steroid dose and have normal physiological parameters. Appropriate advice  Patients on replacement steroids (e.g., Addison’s disease/hypopituitarism) may have a treatment plan to increase their maintenance steroids in the event of illness / injury. This should be followed but they may require monitoring and higher doses for more significant illness / injury. Key points  Adrenal Crisis is a Medical Emergency requiring prompt treatment with Hydrocortisone and IV fluids.  Steroid Dependant Patients can have an Adrenal Crisis triggered when the body’s requirement for corticosteroids increases such as due to infection or trauma as the body is unable to increase its own production.  If extrication requires a head up posture, IV fluids may be required before moving the patient to prevent profound postural hypotension.  Look for an underlying cause that may have triggered the episode and treat that condition too. Further reading

adrenal-crisis

Joint Royal Colleges Ambulance Liaison Committee, Association of Ambulance Chief Executives. Steroid-dependant Patients. JRCALC Clinical Guidelines 2022: Class Professional Publishing 2022. Concern 4 Evidence heard at the inquest confirmed that the investigation lead at WMAS had not been shown the inquest disclosure bundle, which had been disclosed to the legal department at WMAS a number of months prior to the inquest. This bundle contained relevant evidence from a different internal investigation (by WAHT), suggesting that the likely cause of Mr Mason’s deterioration and death was an acute adrenal crisis and not, as had been considered when a coronial referral had initially been made, hyperkalaemia and rhabdomyolysis (following a fall and long lie). This lack of internal co-ordination within WMAS prevented full internal investigation and learning in respect of the care given to Mr Mason by WMAS. The legal department of WMAS did not attend the inquest (it was their right not to) nor were WMAS legally represented by an external solicitor or barrister (it was their right not to be). Greater engagement and participation in the coronial investigation and inquest process would improve the Trust’s ability to learn from patient-safety incidents and enable the legal, governance and safety departments to better co-ordinate such investigations. Response Due to new staff starting within within the WMAS Coroners team, sending the bundle to the Lead investigator was missed on this occasion. Please accept our sincere apologise for this error in administration. The legal team at WMAS aim to attend as many inquests a possible. However, due to the increasing number of inquests throughout the West Midlands it is not possible to attend all inquests. May I once again please pass on my sincere condolences to the family of Mr Mason. I hope this response provides you and the family with the appropriate level of assurance that as a Trust we have dealt with the concerns highlighted within your report. If you require any further assistance, please do not hesitate contact me.
Association of Ambulance NHS / Health Body
12 Jun 2023 PDF
Action Planned

AACE is revising JRCALC guidance to emphasize steroid administration to patients suffering trauma or physiological stress, engaging with the Addison's Disease Self-Help Group and The Addison's Clinical Advisory Panel Chair. AACE is also aware of the development of an educational e-learning package for call handlers to improve understanding of Addison's disease and steroid-dependent patients, which will be trialled in Yorkshire and potentially rolled out to other ambulance services. (AI summary)

View full response
Dear Mr Lane

DAVID ERNEST MASON (DECEASED)

I am writing in response to the preventing future deaths report that was sent to our executive officer at the Association of Ambulance Chief Executives and I respond as our Managing Director on behalf of AACE.

It may be helpful for us to explain that AACE is a private company owned by the English and Welsh Ambulance NHS Trusts. It exists to provide ambulance services with a central organisation that supports, co-ordinates and implements nationally agreed policy. Our primary focus is the ongoing development of the English ambulance services and the improvement of patient care. It is a company owned by NHS organisations and possess the intellectual property rights of the Joint Royal Colleges Ambulance Liaison Committee UK ambulance service clinical practice guidelines (the “JRCALC guidelines”). AACE is not constituted to mandate or instruct ambulance services however it has national influence via the regular meetings of ambulance Chief Executives and Trust Chairs along with a network of national specialist sub- groups.

Your first matter of concern relates to our ‘JRCALC guidance’ not being sufficiently clear that patients who may have suffered trauma or physiological stress also require steroid treatment, to prevent an adrenal crisis. The JRCALC guidelines have been in existence since the 1990’s but it was only in 2022 that we decided that a standalone guideline for steroid dependent patients was needed. We have decided that the wording and emphasis on administering steroids to patients who suffer trauma or physiological stress could have more emphasis placed on it, so we are now in the process of revising our guidance. We worked closely with members of the Addison’s disease self-help group and sought advice from The Addison’s Clinical Advisory Panel Chair in developing our current steroid dependent patients guidance and are now re-engaged with them again to ensure our revised guidance is accurate and will also reflect advice that is given to patients.

With regard to your second matter of concern about the advice given in ambulance control centres to people who call 999. Calls to 999 in the West Midlands region are assessed in accordance with the Department of Health National Guidelines using a process called NHS Pathways (NHSP) and therefore we have no responsibility for making changes to this system. We are aware from West Midlands ambulance service that the mater has been raised with NHSP. We are however aware of the development of an educational e learning package for call handlers so they have a better understanding and awareness of Addison’s disease and steroid dependent patients. The package will be trialled in Yorkshire and is being developed in conjunction with The Pituitary Foundation. Once the learning package has been evaluated as effective, we will aim to push this out to other ambulance services for them to consider using for their own control room staff.

On behalf of AACE, I would like to extend our sincere condolences to the family of David Ernest Mason.

If you have any further questions please do not hesitate to get in touch.
Worcestershire Acute Hospitals NHS / Health Body
12 Jun 2023 PDF
Action Taken

Worcestershire Acute Hospitals NHS Trust has amended its guideline to include clear advice for all patients in the Emergency Department requiring admission, delivered teaching sessions to surgical trainees and T&O junior doctors, shared a lesson of the week, and made changes to ED admission documents to include prompts on time-critical medications. (AI summary)

View full response
Dear Mr Lane Re Regulation 28 Report to Prevent Future Deaths Please accept this letter in response to your Regulation 28 Report to Prevent Future Deaths sent on 19th April 2023, following the Inquest touching on the death of Mr David Mason. In your Regulation 28 report you identified the following matters of concern relating to the Worcestershire Acute Hospitals NHS Trust (WAHT)
1) Evidence heard at the inquest demonstrated that no clinician involved in providing care to Mr Mason (in both the emergency department and the surgical trauma department) appreciated that, as someone who had Addison’s disease and who had suffered the trauma of a fall, long lie and a fractured hip, Mr Mason required additional replacement steroid therapy, to prevent the development of an acute adrenal crisis.
2) The relevant internal Trust guideline disclosed by WAHT (‘Guideline for the management of adrenal insufficiency in adults’) very much focuses on presentations of acute adrenal crisis and procedure- based/perioperative situations, and (save for a small section containing ‘sick day’ rules, which are on the same page as advice to patients and families for long-term condition management) does not emphasise that replacement steroid therapy must be given to patients with adrenal insufficiency who have suffered trauma or physiological stress.
3) Evidence heard at the inquest (relating to the trauma/surgical department at WAHT) suggested that it is likely that many clinicians (including at consultant level) do not have a well-developed understanding of adrenal insufficiency and the crucial importance of administering replacement

Worcestershire Acute Hospitals NHS Trust | Executive Suite, Sky Level 3 | Worcestershire Royal Hospital Charles Hastings Way | Worcester | WR5 1DD Office of the Chief Executive Officer

steroid therapy to patients who, although not presenting as acutely unwell, are at risk of suffering an adrenal crisis.

4) Evidence heard at the inquest confirmed that no prompts exist on emergency department/clerking documentation at WAHT for clinicians to check whether a patient suffers from adrenal insufficiency. Although the inquest was informed that changes have been made in this regard by WAHT to some peri-operative patient documentation, the National Patient Safety Alert (NatPSA/2020/005/NHSPS) requires acute trusts to review admission/assessment/clerking documentation to ensure such prompts are included.

Responding to the concerns raised;
1. In order to raise awareness and educate clinicians, the following actions have been taken. Individual feedback was given and reflection undertaken by clinicians involved in July 2022 (appendix 1). On the 9th May 2023 at the Trauma & Orthopaedic (T&O) Governance meeting attended by 33 multidisciplinary staff including T&O Consultants this case was discussed and reflected upon (appendix 2). A teaching session was delivered by the Deputy Chief Medical Officer to 40+ Surgical trainees at a Regional Teaching Session on the 9th May 2023 (appendix
3). A teaching session highlighting the risk of adrenal insufficiency for T&O Junior Doctors delivered by a consultant Anaesthetist is now given three times per year as part of the induction programme (appendix 4). A Lesson of the Week has been shared on 25th May 2023 (appendix
5), with Governance teams to disseminating it through Divisions, in the Trust “Worcestershire Weekly”, Datix Incident management system and the Trust Intranet page.

2. The Trust guideline, based on National guidance, has been amended to include clear advice for all patients in the Emergency Departments who require admission (appendix 6). Following discussion with our Endocrinology and Emergency Department teams, it was felt that this would be the most effective way of ensuring that clinicians were aware of the need for additional steroid replacement therapy for patients at risk of adrenal crisis due to physiological stress and pain.

3. Covered in point 1 above.

4. Changes have been made to the ED admission documents, implemented 6th June 2023, to include prompts on time critical medications, including steroids, and to consider increasing the dose of steroids (appendix 7). The T&O admission document, as discussed at the Inquest, was updated in October 2022 to include Steroid Management prompts (appendix 8).

I hope that the above addresses your concerns about the quality of our initial review. I have no representations in respect of publication of the Regulation 28 or this response by the Chief Coroner.

Worcestershire Acute Hospitals NHS Trust | Executive Suite, Sky Level 3 | Worcestershire Royal Hospital Charles Hastings Way | Worcester | WR5 1DD Office of the Chief Executive Officer

I shall be grateful if you could kindly send a copy of my response to anyone to whom you copied your Regulation 28 report.
Society for Endocrinology
PDF
Action Planned

The Society for Endocrinology highlights existing resources and the NICE guideline in development, commits to reviewing resources once NICE guidelines are written and ensuring pre-hospital care is covered more clearly, and is liaising with ambulance services to ensure triage information includes the need to send a category 2 ambulance. (AI summary)

View full response
To Whom it May Concern,

Thank you for forwarding us this information. We are so sorry to hear of the death of Mr David Mason, and collectively would like to offer condolences to his family.

We note the circumstances described in the report.

Information available currently states the need for additional hydrocortisone in adrenal insufficiency for trauma and physiological stress https://www.rcpjournals.org/content/clinmedicine/17/3/258 .

All NHS health care providers have been sent the National Patient Safety Alert with gives as an example the death of a patient with a hip fracture, and point 3 states the need to give additional steroids for acute physical illness or trauma https://www.england.nhs.uk/publication/national-patient-safety-alert-steroid- emergency-card-to-support-early-recognition-and-treatment-of-adrenal-crisis-in-adults/. We would strongly recommend that all health and care providers ensure their organization has put processes in place to ensure the four actions on the National Patient Safety Alert have been addressed.

Trauma and physiological stress are within scope for the NICE guideline on adrenal insufficiency currently in development. There is representation from paramedics, Emergency Medicine, General Practice and lay members on the committee so the guidelines will cover pre hospital care. Once guidelines are published there is a plan for another round of communications to disseminate the information.

The Society for Endocrinology will have opportunity to review this when it is shared with stakeholders and provide comments. Also, members of the Society for Endocrinology are on the committee writing the guidelines and will ensure these topics are covered. In terms of Ambulance service, JRCALC has protocols advising on the management of patients with adrenal insufficiency. is liaising with them, at present and we will ensure all protocols align and are clear about the need to give additional oral or IM hydrocortisone in trauma/injury. JRCALC guidelines state anyone can give IM hydrocortisone and we are aware that there is an issue around paramedics and technicians being reminded both groups can administer emergency treatment. This is important as different types of ambulance have different health care professionals working on them.

In terms of the NHSE steroid emergency card, the wording states injury/shock. We will continue our work with both ambulance services and 999/111 services via NHSE patient safety team to ensure this is on the triage information to call handlers so a category 2 ambulance can be sent. All ambulances carry hydrocortisone, and both paramedics and ambulance technicians are able to administer IM hydrocortisone so this should not be a blocker to administration. JRCALC may be able to address this in their guidelines. It is possible thatmore work is needed to disseminate the information available and we can continue working with RCP Patient Safety Committee and NHSE Patient Safety team in this regard. We will also update our resources accordingly.

In order to support health and care providers, the Society for Endocrinology has set up a webpage with resources to help health care teams develop resources to support management of adrenal sufficiency. We will review this once NICE guidelines are written and ensure that pre-hospital care is covered more clearly. We would be happy to work with Worcestershire Acute Hospitals NHS Trust to review their materials if helpful.

We are aware that, in the current climate with pressures on ambulance services and emergency departments, there may be delays in patients with adrenal insufficiency being managed appropriately. We will continue to liaise with the NHSE patient safety team and Royal College of Emergency Medicine to ensure that patients with adrenal insufficiency are given additional hydrocortisone in the appropriate way to prevent further deaths.

Please let us know if you require any further information or clarification.

, Consultant Endocrinologist, Chair of Clinical Committee Consultant Endocrinologist, RCP Patient Safety Committee, Medicines Safety Joint Working Group, NICE Topic Advisor adrenal Insufficiency Guideline , Consultant Endocrinologist, GIRFT Lead

On Behalf of the Clinical Committee of the Society for Endocrinology

Report sections

Investigation and inquest
On 13 March 2022 an investigation was commenced into the death of David Ernest Mason. The investigation concluded at the end of the inquest hearing on 12 April 2023 at Stourport Coroner’s Court, in the Worcestershire Coroner Area. The conclusion (a ‘narrative’ conclusion in Box 4 of the Record of Inquest) was determined as follows:

‘David Mason died as a result of an acute adrenal crisis, caused by Addison’s disease and precipitated by the trauma of a fall and fractured hip. Insufficient administration of steroid medication by medical professionals was a contributory factor in David’s death.’
Circumstances of the death
David Mason was an 82-year-old gentleman with significant medical co-morbidities, including a known diagnosis of Addison’s disease. By March 2022, Mr Mason was becoming more frail and, owing to mobility issues, was suffering from recurrent falls. Mr Mason fell in his bedroom on the evening of 5 March 2022. An ambulance was called but it took a number of hours until paramedics arrived and transported Mr Mason to hospital. Once there, Mr Mason was diagnosed with a fractured hip, as a result of the trauma suffered when he fell.

Mr Mason did not present as acutely medically unwell (as opposed to him having an obvious requirement for trauma assessment, followed by surgery) at any time after the fall or whilst in hospital and no clinician involved in his care appreciated that, without additional steroid medication, he was at high risk of developing an acute adrenal crisis, owing to his primary adrenal insufficiency (Addison’s disease) and the trauma and physiological stress that he had suffered following the fall. In the early hours of 7 March 2022, whilst in a bed on a surgical trauma ward, Mr Mason was found breathing abnormally and was obviously acutely unwell. Mr Mason went into cardiac arrest shortly after and died. Mr Mason had suffered an acute adrenal crisis, which was the cause of his sudden and unexpected deterioration and death.

Following medical evidence heard at the inquest, the cause of death was determined as:

1a – acute adrenal crisis (on a background of a known diagnosis of Addison’s disease) 1b – fractured neck of femur following a fall 2 – frailty

Box 3 of the Record of Inquest (which answered how, when and where Mr Mason came by his death) was determined as:

‘David Mason had been unwell for a number of years, including suffering from primary steroid insuffiency (Addison’s Disease), a condition which required the administration of replacement steroid medication. Owing to significant frailty, David had fallen over at home in the evening of 5 March 2022, suffering a fractured hip (diagnosed in hospital on 6 May 2022, following x-ray). An ambulance was not available for a number of hours owing to demand and resource factors, however paramedics attended on David at home and conveyed him to hospital early in the morning on 6 March 2022. No required additional steroid replacement therapy was administered to David by paramedics. In hospital, no required additional steroid replacement therapy was administered to David by clinicians over a period of approximately 19 hours, which led to David’s sudden deterioration and death in the early hours of 7 March 2022 at the Worcestershire Royal Hospital.’
Inquest conclusion
‘David Mason died as a result of an acute adrenal crisis, caused by Addison’s disease and precipitated by the trauma of a fall and fractured hip. Insufficient administration of steroid medication by medical professionals was a contributory factor in David’s death.’

Similar PFD reports

Shared signals

Related inquiry recommendations

Similar themes

Report details

Reference
2023-0125
Date of report
19 April 2023
Coroner
Nicholas Lane
Coroner area
Worcestershire

Responses identified

Responses identified 6 of 5
All listed responses identified

Organisations named in PFD reports are normally expected to respond within 56 days. Deadline: 14 Jun 2023.

Sent to

Association of Ambulance Chief Executives
National Institute for Health and Care Excellence
NHS England
West Midlands Ambulance Service University NHS Foundation Trust
Worcestershire Acute Hospitals NHS Trust

Source links